Evidence map›Paper›PMID 42597784›Full record

ReviewJPRAS open2026

Delabeling penicillin allergies in plastic and reconstructive surgery: Cefazolin as the cornerstone for antibiotic prophylaxis.

Natalia Mejia, Sajni Parikh, Aryan Gupta, Isabella Ho, Alexander Chang, Gabriel De La Cruz, Adam Walchak, Sameer A Patel

Abstract readReview
In one paragraph

Review in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Natalia MejiaDivision of Plastic and Reconstructive Surgery, Fox Chase Cancer Center/Temple University, Philadelphia, PA, USA.
Sajni ParikhDivision of Plastic and Reconstructive Surgery, Fox Chase Cancer Center/Temple University, Philadelphia, PA, USA.
Aryan GuptaLewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Isabella HoLewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Alexander ChangLewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Gabriel De La CruzDivision of Plastic and Reconstructive Surgery, Temple University Hospital, Philadelphia, PA, USA.
Adam WalchakDivision of Plastic and Reconstructive Surgery, Fox Chase Cancer Center/Temple University, Philadelphia, PA, USA.
Sameer A PatelDivision of Plastic and Reconstructive Surgery, Fox Chase Cancer Center/Temple University, Philadelphia, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cefazolin is frequently used as surgical prophylaxis due to its efficacy in preventing surgical site infections (SSIs). However, in patients with reported history of allergy to penicillin, there is a disproportionate use of alternative antibiotic options for prophylaxis. This practice is associated with increased rates of surgical site infection, secondary infections, longer hospital stays, and higher healthcare costs. The use of these alternative options is based on several misconceptions on antibiotic safety; penicillin allergies are frequently over-recorded in the medical record, with <10% of reported patients being truly allergic to penicillin. Even in the case of true allergy, the risk of reactivity to cefazolin is extremely low due to its unique structure, as compared to penicillin/penicillin-like β-lactams. Improved patient outcomes may be achieved through increased clinician education on the safety of cefazolin for surgical prophylaxis, as well as thorough understanding of the rare cases where its use is truly contraindicated. Similarly, there are currently limited guidelines on the selection of prophylactic agents in the field of plastic surgery. Given the clinical evidence, cefazolin should be considered first in plastic surgery cases where antibiotic prophylaxis is indicated.

Indexed as

CefazolinCross-reactivitySurgical antibiotic prophylaxisSurgical site infectionΒ-lactam allergy

Identifiers

PMID42597784
PMCPMC13470567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.